default author photo

Isabelle-Laure Ray-Coquard

University of Claude Bernard Lyon 1 - Medical Oncology Department

Lyon

France

  • University of Claude Bernard Lyon 1 - Medical Oncology Department

SCHOLARLY PAPERS

10

DOWNLOADS

533

TOTAL CITATIONS

0

Scholarly Papers (10)

Actions:
Email selected abstracts
1.

Survival Prognostic and Surrogate Values of the Early Modeled Ca-125 Kelim Score in First-Line Treatment of Ovarian Cancer: Results from The Gcig Individual Patient Data Meta-Analysis

Number of pages: 38 Posted: 13 Apr 2022
Pauline Corbaux, Benoit You, Rosalind M. Glasspool, Nozomu Yanaihara, Anna V. Tinker, Kristina Lindemann, Isabelle-Laure Ray-Coquard, Mansoor Raza Mirza, Fabien Subtil, Olivier Colomban, Julien Péron, Eleni Karamouza, Iain McNeish, Samantha Hinsley, Tatsuo Kagimura, Stephen Welch, Liz-Anne Lewsley, Xavier Paoletti, Xavier Paoletti and Adrian Cook
University of Claude Bernard Lyon 1 - UCBL/HCL, Université Lyon 1 - Faculty of Medicine Lyon-Sud, University of Glasgow - Beatson West of Scotland Cancer Centre, Jikei University - School of Medicine, BC Cancer, The Norwegian Radium Hospital Montebello, University of Claude Bernard Lyon 1 - Medical Oncology Department, European Society of Gynaecological Oncology (ESGO), Université Lyon 1, Université Lyon 1 - Faculty of Medicine Lyon-Sud, Institut de Cancérologie des Hospices Civils de Lyon - Centre Hospitalier Lyon-Sud, University of Paris-Saclay - Institut Gustave Roussy, Imperial College London, University of Glasgow - Beatson West of Scotland Cancer Centre, Foundation for Biomedical Research and Innovation (FBRI), University of Western Ontario - London Health Sciences Centre, University of Glasgow, College of Medical, Veterinary & Life Sciences, Beatson West of Scotland Cancer Centre, Cancer Research UK Clinical Trials Unit, Institut Curie - Department of BiostatisticsUniversity of Paris - Faculty of Medicine Paris and University College London - MRC Clinical Trials Unit
Downloads 103 (674,591)

Abstract:

Loading...

ovarian neoplasms, antigen, CA-125, kinetics, chemosensitivity, prognostic biomarker, surrogacy

2.

Avelumab Alone or in Combination with Chemotherapy vs Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): A Randomised, Open-Label, Phase 3 Study

Number of pages: 52 Posted: 28 Oct 2020
Eric Pujade-Lauraine, Keiichi Fujiwara, Jonathan A. Ledermann, Amit M. Oza, Rebecca S. Kristeleit, Isabelle-Laure Ray-Coquard, Gary E. Richardson, Cristiana Sessa, Kan Yonemori, Susana Banerjee, Alexandra Leary, Anna V. Tinker, Kyung Hae Jung, Radoslaw Madry, Sang-Yoon Park, Sang-Yoon Park, Charles K. Anderson, Fabian Zohren, Ross A. Stewart, Caimiao Wei, Samuel S. Dychter and Bradley J. Monk
ARCAGY-GINECO, Saitama Medical University International Medical Center (SIMC), University College London - UCL Cancer Institute, University of Toronto - Princess Margaret Cancer Centre, University College London - UCL Cancer Institute, University of Claude Bernard Lyon 1 - Medical Oncology Department, Cabrini Hospital - Department of Medical Oncology, Ospedale San Giovanni - Oncology Institute of Southern Switzerland (IOSI), National Cancer Center Hospital - Department of Breast and Medical Oncology, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Université Paris XI Sud - Gustave Roussy Cancer Campus, BC Cancer, University of Ulsan - Department of Oncology, Poznan University of Medical Sciences - Department of Oncology, National Cancer Center - Center for Uterine CancerNational Cancer Center, Korea - Center for Gynecologic Cancer, Willamette Valley Cancer Institute and Research Center, Pfizer Oncology, Pfizer Oncology, Pfizer, Inc. - Pfizer Global Biometrics and Data Management, Pfizer Oncology and University of Arizona - College of Medicine, Arizona Oncology (US Oncology Network)
Downloads 101 (684,672)

Abstract:

Loading...

ovarian cancer, Avelumab, PD-L1, Phase 3, immune checkpoint inhibitor

3.

Survival and Incidence of COVID-19 After SARS-CoV-2 Vaccination in a Series of 2391 Cancer Patients

Number of pages: 22 Posted: 22 Nov 2021
Pierre Heudel, Bertrand Favier, Marie-Laure Solodky, Souad Assaad, Natacha Chaumard, Olivier Tredan, Thomas Bachelot, Isabelle-Laure Ray-Coquard, Bruno Russias, Marie-Line Fournier, Benedicte Mastroianni, Virginie Avrillon, Anne-Sophie Michallet, Philippe Zrounba, Sylvie Chabaud, David Pérol and Jean-Yves Blay
University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Department of Pharmacy, University of Claude Bernard Lyon 1 - Department of Medicine of Health Care Workers, University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Department of Pharmacy, University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Department DCSEI, University of Claude Bernard Lyon 1 - Department DCSEI, University of Claude Bernard Lyon 1 - Department of Surgery, University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Department of Hematology, University of Claude Bernard Lyon 1 - Department of Surgery, University of Claude Bernard Lyon 1 - Department of Clinical Research Centre, University of Claude Bernard Lyon 1 - Department of Clinical Research Centre and University of Claude Bernard Lyon 1 - Medical Oncology Department
Downloads 75 (837,727)

Abstract:

Loading...

Cancer, COVID-19, vaccination, risk factors, death

4.

A Prospective Exposed-Unexposed Cohort Study Comparing Time-to-Pregnancy in Patients with Previous Breast Cancer and Controls from a Collaborative Research Network: Results after Three Years of Follow-Up

Number of pages: 46 Posted: 24 Jan 2025
Anne-Sophie Hamy-Petit, Agathe Chabassier, Clara Sebbag, Christine Rousset-Jablonsk, Clémentine Berkach, Isabelle-Laure Ray-Coquard, Laura Sablone, Lauren Darrigues, Elise Dumas, Angélique Bobrie, William Jacot, Marc Espié, Sylvie Giacchetti, Floriane Jochum, Aullène Toussaint, Geneviève Plu-Bureau, Lorraine Maitrot-Mantelet, Anne Gompel, Paul Gougis, Raphaelle Bas, Christine Decanter, Bernard Asselain, Charles Coutant, Lili Sohn, Guillemette Jacob, Claire Saule, Sophie Frank, Florence Coussy and Fabien Reyal
Institut Curie - Department of Medical Oncology, Sorbonne University, PSL Research University - Institut Curie, Centre Léon Berard - Department of Surgery, Assistance Publique-Hôpitaux de Paris - Hôpital Saint-Louis, University of Claude Bernard Lyon 1 - Medical Oncology Department, PSL Research University - Institut Curie, PSL Research University - Institut Curie, Université Paris Cité, Université Montpellier I, University of Montpellier, Assistance Publique-Hôpitaux de Paris - Hôpital Saint-Louis, Hopital Saint-Louis, Université Paris Cité, PSL Research University - Institut Curie, APHP Hospital Cochin - Unité de gynécologie médicale, Université Paris Cité, Université Paris Cité, Sorbonne University - Hôpital Pitié-Salpêtrière, PSL Research University - Institut Curie, University of Lille II - Centre Hospitalier Régional de Lille, UNICANCER, Centre Georges-François Leclerc - Department of Medical Oncology, Seintinelles Research Network, Seintinelles Research Network, PSL Research University - Institut Curie, PSL Research University - Institut Curie, Institut Curie - Department of Medical Oncology and PSL Research University - Institut Curie
Downloads 70 (875,328)

Abstract:

Loading...

breast cancer, fertility, pregnancy, time to pregnancy, oncology, treatment, neonatal outcomes, delivery, artificial reproductive technology

5.

Early Clinical and Molecular Biomarkers in Advanced Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy: Chiva Phase Ii Gineco Trial

Number of pages: 22 Posted: 07 Oct 2024
Felix Blanc-Durand, Yahia Adnani, Benoit You, Gaetan De Rauglaudre, Isabelle-Laure Ray-Coquard, Pierre Combe, Cyril Abdeddaim, Florence JOLY, Gwenael Ferron, Clotilde Deldycke, Olivier Colomban, Marie Christine Kaminsky, Jerome Meunier, Jerome Alexandre, Coriolan L. Lebreton, Laurence Venat, Laure Favier, Christophe Louvet, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Laure Chardin, Catherine Genestie, Pierre Alexandre Just, Etienne Rouleau and Alexandra Leary
University of Paris-Saclay - Institut Gustave Roussy, University of Paris-Saclay - Institut Gustave Roussy, Université Lyon 1 - Faculty of Medicine Lyon-Sud, affiliation not provided to SSRN, University of Claude Bernard Lyon 1 - Medical Oncology Department, affiliation not provided to SSRN, University of Lille II - Centre Oscar Lambret, Université de Caen, Institut Claudius Regaud, affiliation not provided to SSRN, Université Lyon 1 - Faculty of Medicine Lyon-Sud, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Bordeaux - Institut Bergonié, University of Limoges - CHU Limoges, affiliation not provided to SSRN, Institut Mutualiste Montsouris, Western Cancer Institute, ARCAGY-GINECO, Gustave Roussy, Gustave Roussy, affiliation not provided to SSRN, Gustave Roussy and Université Paris XI Sud - Gustave Roussy Cancer Campus
Downloads 46 (1,109,210)

Abstract:

Loading...

Ovarian cancer, neoadjuvant chemotherapy, biomarkers, homologous recombination deficiency, TILS

6.

Efficacy of Secondary Cytoreductive Surgery for Relapsed Ovarian Low-Grade Serous Carcinoma: A Multicenter Analysis from French Tmrg Network

Number of pages: 27 Posted: 21 Apr 2025
Thomas Gaillard, Thomas Gaillard, Judicael Hotton, Enora Laas, Frederic Marchal, Cécile Loaec, Pierre-Emmanuel Colombo, Gwenael Ferron, Anne-Sophie Bats, Sebastien Gouy, Claire Bonneau, Floriane Jochum, Frédéric Guyon, Florence JOLY, Christophe Pomel, Dominique Berton-Ruigaud, Navid Mokarram-Dorri, Thibault De La Motte Rouge, Isabelle-Laure Ray-Coquard and Fabrice Lecuru
École Normale Supérieure - PSL Research University - Institut CurieInstitut Curie - Breast, Gynecology and Reconstructive Surgery Department, affiliation not provided to SSRN, PSL Research University - Institut Curie, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Montpellier - Institute for Cancer Research in Montpellier, Institut Claudius Regaud, affiliation not provided to SSRN, Gustave Roussy, PSL Research University - Institut Curie, Université Paris Cité, University of Bordeaux - Institut Bergonié, Université de Caen, Centre Jean Perrin, affiliation not provided to SSRN, Aix-Marseille University - Institut Paoli-Calmettes, Institut Curie - Department of Medical Oncology, University of Claude Bernard Lyon 1 - Medical Oncology Department and PSL Research University - Institut Curie
Downloads 36 (1,236,159)

Abstract:

Loading...

Low-Grade Serous Ovarian Cancer, Secondary Cytoreductive Surgery, Recurrence, Progression-Free Survival, Overall Survival, Retrospective Study

7.

Parp Inhibitors as Maintenance Therapy in Ovarian Cancer after Platinum-Sensitive Recurrence: Real-World Experience from the Unicancer Network

Number of pages: 25 Posted: 20 Dec 2023 Last Revised: 29 Mar 2024
Nicolas Rippstein, Christophe Zemmour, Manuel Rodrigues, Isabelle-Laure Ray-Coquard, Laurence Gladieff, Patricia Pautier, Jean Sebastien Frenel, Hélène Costaz, Coriolan Lebreton, Christophe Pomel, Pierre-Emmanuel Colombo, Frédéric Marchal, Cécile Guillemet, Thibault De La Motte Rouge, Lauriane Eberst, Lise Bosquet, Elise Deluche and Renaud Sabatier
University Hospital of Limoges, Paoli-Calmettes Institute, University of Paris, University of Claude Bernard Lyon 1 - Medical Oncology Department, Institut Claudius Regaud, Université Paris XI Sud - Gustave Roussy Cancer Campus, Institut de Cancérologie de l’Ouest Pays de Loire, Centre Georges-François Leclerc - Department of Medical Oncology, University of Bordeaux - Department of Medical Oncology, Université de Clermont Auvergne, University of Montpellier - Institute for Cancer Research in Montpellier, University of Lorraine, Centre Henri Becquerel, Institut Curie - Department of Medical Oncology, Institut de Cancérologie de Strasbourg Europe, UNICANCER, Limoges University Hospital and Aix-Marseille-Univ
Downloads 36 (1,236,159)

Abstract:

Loading...

Real word data. PARP inhibitor. Platinum-sensitive. Maintenance therapy. Recurrent ovarian cancer

8.

COVID-19 Vaccination Before Immune Checkpoint Inhibitor Initiation and the Overall Survival of Patients with Advanced Cancer

Number of pages: 11 Posted: 10 Jan 2026
Jean-Yves Blay, Pierre E. HEUDEL, Virginie Avrillon, Benedicte Mastroianni, Helene Boyle, Souad Assaad, Isabelle-Laure Ray-Coquard, Jean-Philippe Spano and Maurice Perol
University of Claude Bernard Lyon 1 - Medical Oncology Department, Institut d’Hématologie et d’Oncologie Pédiatrique (iHOPe) - Centre Léon Bérard, University of Claude Bernard Lyon 1 - Medical Oncology Department, affiliation not provided to SSRN, University of Claude Bernard Lyon 1 - Centre Léon Bérard, University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Claude Bernard Lyon 1 - Medical Oncology Department, affiliation not provided to SSRN and University of Claude Bernard Lyon 1 - Centre Léon Bérard
Downloads 31 (1,304,549)

Abstract:

Loading...

COVID-19, Vaccination, Cancer, immune checkpoint inhibitor, PD1, Survival

9.

Long-term fatigue, neurotoxicity, cognitive and sexual disorders after chemotherapy in ovarian germ cell and sex cord–stromal tumors: subtype-specific findings from the GINECO-TMRG case control study

Number of pages: 36 Posted: 29 Apr 2026
Coraline Dubot-Poitelon, Djihane Ahmed-Lecheheb, Isabelle-Laure Ray-Coquard, Justine Lequesne, Patricia Pautier, Tiphaine Renaud, Frédéric Selle, Dominique Berton-Ruigaud, Sophie Frank, Thibault De La Motte Rouge, Elsa Kalbacher, Magali Provensal, Cyriac Blonz, Hubert Orfeuvre, Jérôme Alexandre, Paule Augereau, Cedric Nadeau, Jean-Emmanuel Kurtz, Brunhilde Hanvic, Brice Fresneau, François Christy, Jean-Michel Grellard, Bénédicte Clarisse, François Gernier and Florence JOLY
Université de Caen, affiliation not provided to SSRN, University of Claude Bernard Lyon 1 - Medical Oncology Department, affiliation not provided to SSRN, Gustave Roussy, Bergonié Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, PSL Research University - Institut Curie, Institut Curie - Department of Medical Oncology, affiliation not provided to SSRN, Paoli-Calmettes Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, Cochin University Hospital, Institut de Cancerologie de l’Ouest, CHU Poitiers, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Angers - Cancer and Radiation Team, affiliation not provided to SSRN, Centre François Baclesse, affiliation not provided to SSRN, Centre François Baclesse and Université de Caen
Downloads 19 (1,470,786)

Abstract:

Loading...

Ovarian Germ cell tumors, Sex cord stromal tumors, Long-term side effects, Survivorship, Long-term Quality of life, Menopause

10.

Survivorship care plan: correlation between practitioners and a digital tool (LOG-after)

Number of pages: 19 Posted: 10 Mar 2026
Amandine BERTRAND, Isabelle Pellier, Marie-Dominique Tabone, Véronique Christophe, Isabelle-Laure Ray-Coquard, Christine Rousset-Jablonsk, Les Aguerris, Pascal Veillon and Charlotte Demoor-Goldschmidt
University of Claude Bernard Lyon 1 - Centre Léon Bérard, University of Angers, affiliation not provided to SSRN, University of Claude Bernard Lyon 1 - Centre Léon Bérard, University of Claude Bernard Lyon 1 - Medical Oncology Department, Centre Léon Berard - Department of Surgery, affiliation not provided to SSRN, University of Angers - CHU Angers and University of Angers - CHU Angers
Downloads 16 (1,491,251)

Abstract:

Loading...

AYA, pediatric cancer, survivorship care plans, LOG-after, digital tool, LTFU